Stay updated on Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial
Sign up to get notified when there's something new on the Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial page.

Latest updates to the Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded 'No longer looking for participants' to the study history, indicating recruitment has ceased. Updated the record's version history with 'Revision: v3.6.0' and removed 'Revision: v3.5.5' to reflect the latest version.SummaryDifference0.3%

- Check20 days agoChange DetectedA new revision entry v3.5.5 is added to the study record history, indicating a newer version of the record has been submitted.SummaryDifference0.1%

- Check42 days agoChange DetectedA new revision entry v3.5.4 was added to the Record History, and the older v3.5.3 entry was removed.SummaryDifference0.1%

- Check49 days agoChange DetectedThe trial's recruitment status updated from Recruiting to Active, not recruiting. The record is augmented with key sections (Contacts/Locations, Study Design, Study Status, and Recruitment Status) to present current study details and contact information.SummaryDifference0.7%

- Check63 days agoChange DetectedThe page’s footer revision indicator was updated from v3.5.2 to v3.5.3, reflecting a software/version change rather than any change to the clinical trial record.SummaryDifference0.1%

- Check70 days agoChange DetectedA new revision (v3.5.2) dated 2026-04-13 adds Oversight and Study Status to the record history; the previous revision (v3.5.0) dated 2025-10-09 is removed.SummaryDifference0.5%

Stay in the know with updates to Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial page.